Firms
Theme

SRE

Sempra · NYSE

News

3 latest

Zacks Investment Research

How to Boost Your Portfolio with Top Oils and Energy Stocks Set to Beat Earnings

Zacks highlights oil and energy stocks with positive Earnings Surprise Prediction (ESP) metrics ahead of November earnings reports. Sempra (SRE) has a +2.25% ESP with a Hold rating, while Devon Energy (DVN) shows a +3.63% ESP with a Buy rating. Both stocks are positioned to potentially beat earnings expectations based on analyst estimate revisions.

Zacks Investment Research

How to Find Strong Oils and Energy Stocks Slated for Positive Earnings Surprises

The article explains how to use the Zacks Earnings ESP (Expected Surprise Prediction) tool to identify stocks likely to beat earnings estimates. It highlights that combining positive ESP with a Zacks Rank #3 or stronger resulted in positive earnings surprises 70% of the time with ~28% average annual returns. Two energy stocks are featured as examples: Oneok Inc. and Sempra, both with positive ESP figures suggesting potential earnings beats.

Zacks Investment Research

These 2 Oils and Energy Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks highlights two energy stocks with positive Earnings Surprise Prediction (ESP) metrics that could beat quarterly earnings expectations. Sempra (SRE) has a +1.86% ESP ahead of its November 4, 2026 earnings report, while Exxon Mobil (XOM) shows a +9.97% ESP before reporting on October 30, 2026. Both stocks carry a Zacks Rank #3 (Hold) rating.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $SRE · 0 threads

Sign in to post on $SRE

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev